Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.02 -0.05 (-2.42%)
At close: Oct 1, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Accounts Payables (2024 - 2026)

Updated

Polaryx Therapeutics (PLYX) recorded Accounts Payables of $683,000 in Q2 2026, down 19.6% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Accounts Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Polaryx Therapeutics reported Accounts Payables of $470,000, up 552.8% from FY2024.

  • Across earlier years, Accounts Payables came in at $72,000 in FY2024.
  • Quarterly Accounts Payables has ranged from $72,000 in Q4 2024 to $850,000 in Q1 2026 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Polaryx Therapeutics 103.18 Mn 78.80 Mn - 683,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 683,000.00
Mar 31, 2026 850,000.00
Dec 31, 2025 470,000.00
Dec 31, 2024 72,000.00
API Access

Polaryx Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=PLYX&period=max&api_key=YOUR_API_KEY